Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multi-centre Prospective Pharmacokinetic Evaluation of Antifungal Drug Exposure in Intensive Care Unit Patients Receiving Conventional Dosing Regimens

NCT03136926 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT03136926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03136926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multi-centre Prospective Pharmacokinetic Evaluation of Antifungal Drug Exposure in Intensive Care Unit Patients Receiving Conventional Dosing Regimens
Lead sponsor
The University of Queensland
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
December 31, 2018
Enrollment
150 (estimated)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

antifungal agents